Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUSTAINED KETAMINE EFFECTIVENESS for SUICIDAL IDEATION

NCT06806475 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06806475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06806475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUSTAINED KETAMINE EFFECTIVENESS for SUICIDAL IDEATION
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
December 1, 2023
Completion date
September 23, 2024
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, suicide